SBIR Phase II: Engineered Induced Thymic Epithelial Cells for Novel T Cell Immunotherapies — NSF Award to RATTAN LIFE SCIENCE INC.
The broader impact of this Small Business Innovation Research (SBIR) Phase II project is the development of novel off-the-shelf immunotherapies for patients with advanced cancer and limited treatment options. This project is enabled by a proprietary platform technology developed in Phase I of the project for mass produ
| Award title | SBIR Phase II: Engineered Induced Thymic Epithelial Cells for Novel T Cell Immunotherapies |
|---|---|
| Award ID | 2451182 |
| Awardee | RATTAN LIFE SCIENCE INC. |
| City | SUNNYVALE |
| State | CA |
| Amount obligated | $1,250,000 |
| Principal investigator | Hui Gai |
| Program | SBIR Phase II |
| Start date | 06/01/2025 |
| Abstract | The broader impact of this Small Business Innovation Research (SBIR) Phase II project is the development of novel off-the-shelf immunotherapies for patients with advanced cancer and limited treatment options. This project is enabled by a proprietary platform technology developed in Phase I of the project for mass production of a cell-based treatment with substantial improvements in molecular and functional fidelity. This novel platform offers a scalable, renewable approach for developing cost-ef |
| Source | NSF Awards |
$799/mo
Try NSFGrants →